Straumann Holding AG Net Income 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly net income history and growth rate from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Straumann Holding AG net income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG net income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual net income for 2024 was $0.441B, a 60.92% increase from 2023.
  • Straumann Holding AG annual net income for 2023 was $0.274B, a 39.84% decline from 2022.
  • Straumann Holding AG annual net income for 2022 was $0.456B, a 5.14% increase from 2021.
Straumann Holding AG Annual Net Income
(Millions of US $)
2024 $441
2023 $274
2022 $456
2021 $433
2020 $97
2019 $308
2018 $279
2017 $277
2016 $233
2015 $74
2014 $173
2013 $109
2012 $39
2011 $80
Straumann Holding AG Quarterly Net Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.458B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.300B 21.81
Becton Dickinson (BDX) United States $48.551B 12.02
Cardinal Health (CAH) United States $37.055B 19.41
Labcorp (LH) United States $20.745B 16.83
West Pharmaceutical Services (WST) United States $15.044B 31.53
Cooper (COO) United States $13.399B 17.27
Align Technology (ALGN) United States $12.939B 25.68
Henry Schein (HSIC) United States $8.467B 14.52
Merit Medical Systems (MMSI) United States $5.534B 26.75
DENTSPLY SIRONA (XRAY) United States $3.113B 9.30
CONMED (CNMD) United States $1.713B 12.82
STAAR Surgical (STAA) United States $0.827B 0.00
Lifevantage (LFVN) United States $0.157B 16.17
Pro-Dex (PDEX) United States $0.128B 14.01